BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8625114)

  • 1. Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus.
    Youssef EM; Matsuda T; Takada N; Osugi H; Higashino M; Kinoshita H; Watanabe T; Katsura Y; Wanibuchi H; Fukushima S
    Cancer; 1995 Aug; 76(3):358-66. PubMed ID: 8625114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIB-1 index is unlikely to predict relapse-free survival in patients who underwent R0-esophagectomy for esophageal squamous cell carcinoma.
    Minami T; Yuasa N; Miyake H; Takeuchi E; Nagai H; Ito M; Kiriyama A; Miyata K
    Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29272372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of tumour cell proliferation in squamous cell carcinomas of the oesophagus.
    Sarbia M; Bittinger F; Porschen R; Dutkowski P; Torzewski M; Willers R; Gabbert HE
    Br J Cancer; 1996 Oct; 74(7):1012-6. PubMed ID: 8855967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
    Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
    Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma.
    Lam KY; Law SY; So MK; Fok M; Ma LT; Wong J
    Cancer; 1996 Jan; 77(1):7-13. PubMed ID: 8630942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
    Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
    Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de Nictolis M; Muzzioli M; Fabris N; Romanini C; Biagini G
    Gynecol Oncol; 1995 Jul; 58(1):28-33. PubMed ID: 7789886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceleration of the proliferative activity of esophageal carcinoma with invasion beyond the muscularis mucosae; immunohistochemical analysis using MIB-1 for the Ki-67 antigen.
    Chino O; Osamura Y; Kise Y; Nishi T; Shimada H; Tanaka M; Kijima H; Makuuchi H
    Tokai J Exp Clin Med; 2007 Dec; 32(4):115-20. PubMed ID: 21318949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma.
    Ikeguchi M; Saito H; Katano K; Tsujitani S; Maeta M; Kaibara N
    J Am Coll Surg; 1997 Oct; 185(4):398-403. PubMed ID: 9328389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the proliferative activity of superficial esophageal carcinoma using MIB-1 immunostaining for the Ki-67 antigen.
    Chino O; Makuuchi H; Shimada H; Machimura T; Mitomi T; Osamura RY
    J Surg Oncol; 1998 Jan; 67(1):18-24. PubMed ID: 9457251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prognostic impact of growth fraction parameters in advanced stage laryngeal squamous cell carcinoma.
    Valente G; Giusti U; Kerim S; Gabriele P; Motta M; Ragona R; Navone R; Palestro G
    Oncol Rep; 1999; 6(2):289-93. PubMed ID: 10022991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is MIB-1 proliferation index a predictor for response to neoadjuvant therapy in patients with esophageal cancer?
    Imdahl A; Jenkner J; Ihling C; Rückauer K; Farthmann EH
    Am J Surg; 2000 Jun; 179(6):514-20. PubMed ID: 11004343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond the mucosa: immunohistochemical analysis of Ki-67 and p53 antigen in relation to histopathologic findings.
    Kawamura T; Goseki N; Koike M; Takizawa T; Endo M
    Cancer; 1996 Mar; 77(5):843-9. PubMed ID: 8608473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of MIB-1 in advanced ovarian carcinoma as determined using automated immunohistochemistry and quantitative image analysis.
    Layfield LJ; Saria EA; Berchuck A; Dodge RK; Thompson JK; Conlon DH; Kerns BJ
    J Surg Oncol; 1997 Dec; 66(4):230-6; discussion 236-7. PubMed ID: 9425325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary mucoepidermoid carcinoma of the esophagus.
    Chen S; Chen Y; Yang J; Yang W; Weng H; Li H; Liu D
    J Thorac Oncol; 2011 Aug; 6(8):1426-31. PubMed ID: 21587086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences and relationships of thymidine phosphorylase expression in tumor-associated macrophages and cancer cells in squamous cell carcinoma of the esophagus.
    Koide N; Nishio A; Hiraguri M; Kishimoto K; Nakamura T; Adachi W; Amano J
    Dis Esophagus; 2002; 15(1):67-73. PubMed ID: 12060046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma.
    Müller W; Schneiders A; Meier S; Hommel G; Gabbert HE
    Br J Cancer; 1996 Sep; 74(5):759-65. PubMed ID: 8795579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histochemical study of vascular endothelial growth factor in squamous cell carcinoma of the esophagus.
    Koide N; Nishio A; Kono T; Yazawa K; Igarashi J; Watanabe H; Nimura Y; Hanazaki K; Adachi W; Amano J
    Hepatogastroenterology; 1999; 46(26):952-8. PubMed ID: 10370645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the proliferation index in gastric carcinomas with the monoclonal antibody MIB 1.
    Broll R; Mahlke C; Best R; Schimmelpenning H; Strik MW; Schiedeck T; Bruch HP; Duchrow M
    J Cancer Res Clin Oncol; 1998 Jan; 124(1):49-54. PubMed ID: 9498835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of Ki-67 expression for patients with laryngeal squamous cell carcinoma primarily treated by total laryngectomy.
    Acikalin MF; Oner U; Tel N; Paşaoğlu O; Cakli H; Colak E
    Eur Arch Otorhinolaryngol; 2004 Aug; 261(7):376-80. PubMed ID: 14605812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.